Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445825/
https://www.ncbi.nlm.nih.gov/pubmed/33662392
http://dx.doi.org/10.1016/j.xphs.2021.03.003
_version_ 1784568735018778624
collection PubMed
description
format Online
Article
Text
id pubmed-8445825
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84458252021-09-22 Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053] J Pharm Sci Erratum Elsevier 2021-04 /pmc/articles/PMC8445825/ /pubmed/33662392 http://dx.doi.org/10.1016/j.xphs.2021.03.003 Text en © 2021 American Pharmacists Association. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Erratum
Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title_full Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title_fullStr Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title_full_unstemmed Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title_short Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
title_sort erratum to “rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: case-study with non-replicating rotavirus (nrrv) vaccine antigens” [j pharm sci 110 (2021) 1042–1053]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445825/
https://www.ncbi.nlm.nih.gov/pubmed/33662392
http://dx.doi.org/10.1016/j.xphs.2021.03.003

Ejemplares similares